CSL Limited (ASX: CSL)
Australia
· Delayed Price · Currency is AUD
280.00
-6.95 (-2.42%)
May 17, 2024, 4:10 PM AEST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 135.31 billion as of May 17, 2024.
Market Cap
135.31B
Enterprise Value
159.56B
Revenue
31.63B
Ranking
n/a
PE Ratio
36.89
Stock Price
280.00
Market Cap Chart
Since June 30, 1994, CSL Limited's market cap has increased from 366.81M to 135.31B, an increase of 36,788.56%. That is a compound annual growth rate of 21.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 135.31B | 2.07% |
Jun 30, 2023 | 132.56B | 3.00% |
Jun 30, 2022 | 128.71B | -33.74% |
Jun 30, 2021 | 194.23B | -0.40% |
Jun 30, 2020 | 195.01B | 32.79% |
Jun 30, 2019 | 146.86B | 12.57% |
Jun 30, 2018 | 130.46B | 38.64% |
Jun 30, 2017 | 94.10B | 21.27% |
Jun 30, 2016 | 77.60B | 27.03% |
Jun 30, 2015 | 61.09B | 26.71% |
Jun 30, 2014 | 48.21B | 6.47% |
Jun 30, 2013 | 45.28B | 47.74% |
Jun 30, 2012 | 30.65B | 14.54% |
Jun 30, 2011 | 26.76B | -3.23% |
Jun 30, 2010 | 27.65B | -3.51% |
Jun 30, 2009 | 28.65B | -2.55% |
Jun 30, 2008 | 29.40B | 22.25% |
Jun 30, 2007 | 24.05B | 64.16% |
Jun 30, 2006 | 14.65B | 48.07% |
Jun 30, 2005 | 9.90B | 66.40% |
Jun 30, 2004 | 5.95B | 105.36% |
Jun 30, 2003 | 2.90B | -60.78% |
Jun 30, 2002 | 7.38B | -30.87% |
Jun 30, 2001 | 10.68B | 61.91% |
Jun 30, 2000 | 6.60B | 156.89% |
View and export this data all the way back to 1994.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ResMed Inc. | 48.63B |
Cochlear Limited | 22.20B |
Fisher & Paykel Healthcare Corporation Limited | 15.59B |
Sonic Healthcare Limited | 12.98B |
Pro Medicus Limited | 12.40B |
Ramsay Health Care Limited | 11.66B |
Telix Pharmaceuticals Limited | 4.99B |
Neuren Pharmaceuticals Limited | 2.75B |